Bradenton Neurology, Inc

W. Alvin McElveen, M.D.

Frequently Asked Questions
Medical Links
Contact Bradenton Neurology
W. Alvin McElveen, M.D.
Ralph Gonzalez, M.D.
Douglas Sinclair, D.O.

BRADENTON NEUROLOGY                                                                    

3930 8th Avenue West                                                 

Bradenton, FL 34205                                                                                                                                                         

Telephone: 941-746-3115                                                                        

FAX:           941-746-3201   

BRADENTON RESEARCH CENTER                                                      

3924 9th Ave West

Bradenton, FL 34205

Telephone: 941-708-0005

FAX:            941-748-1156



Emory University: Atlanta, GA

Dates attended: 1967-70


Honor Societies:        Sigma Pi Sigma (National Physics Honor Society)

                                          Alpha Epsilon Upsilon         


Medical College of Georgia: Augusta, GA

Dates Attended: 1970-74

Degree Obtained: M.D.


Tucson Hospitals Medical Education Program: Tucson AZ

Internship in Internal Medicine: July, 1974-June, 1975

Resident in Internal Medicine: July, 1975-June, 1976


University of Arizona Department of Neurology

Neurology Resident: July, 1976-June, 1978

Chief Resident, Neurology: July, 1978-June, 1979

Multiple Sclerosis Comprehensive Treatment Training Program

University of Texas Southwestern Medical School

June, 2002


Private Practice in Neurology: Bradenton, FL 1979-Present


Assistant Clinical Professor of Neurology

University of South Florida, Tampa, FL, 1981-1985


Manatee Memorial Hospital: Active Staff

Medical Executive Committee 1981-83

Lakewood Ranch Medical Center

Chairman, Neurosciences Committee, Blake Medical Center, 2004-2009

Medical Director, Stroke Program, Blake Medical Center, 2004-2009



PROFESS Investigators Advisory Panel 2005

Epilepsy Foundation of Southwest Florida: Professional Advisory Board

Director, Manatee County Epilepsy Foundation Clinic: 1979-Present

American Academy of Neurology: Fellow

 American Academy of Neurology:  Critical Care and Emergency  Neurology Section

 American Academy of Neurology: Stroke and Vascular  Neurology Section

 American Academy of Neurology: Multiple Sclerosis Section

American Stroke Association

Florida Medical Association

Manatee County Medical Society

American Medical Association

American Society of Neuroimaging

American Academy of Physicians and Investigators                       


Diplomate of the American Board of Psychiatry and Neurology, a Member of American Board of Medical Specialties

Specialty of Neurology, April, 1981

Subspecialty of Vascular Neurology, May, 2005

Certified, American Board of Independent Medical Examiners, 1996, 2001, 2006

Certification in MRI/CT, American Society of Neuroimaging: January 29, 2000




PARKE DAVIS: Cognex Access Program, 1992-93

BAYER: Metrifonate for Alzheimer’s, 1997-98


TAKEDA: Rozerem in Alzheimer’s sleep disturbance 2006

MARTEK: DHA in mild cognitive impairment. 2005-7

NOVARTIS:cena713d2340. Exelon patch for Alzheimer’s Disease. 2007


WALLACE: Felbatol LIFE Program, 1994

PARKE DAVIS: Neurontin Dosage Titration Study, 1994

ORTHO-MCNEIL: Topamax Drug Initiation Trial, 1997

UCB PHARMA: K.E.E.P.E.R Study on Keppra for Seizures, 2000

GLAXO: TARGET Study on Lamictal, 2000

GLAXO SMITHKLINE: LAM40117 (Lamictal) study: 2002

SCHWARZ PHARMA:  SPM 927 as adjunctive therapy for epilepsy: SP 754 and 756 studies, 2004

ORTHO-MCNEIL:   Topirimate CAPSS-272: 2004

GLAXO SMITHKLINE:  LAM 40124  assessment for behavioral changes with lamotrigine and leveracitam.

EISAI: E2007-A001-206 study for refractory partial onset seizures

KING PHARMACEUTICALS: Vanquix epipen for acute repetitive seizures. 2007.


SANDOZ: DHE 4,5 Nasal Spray Study, 1995

GLAXO: Imitrex Postmarketing Surveillance Study, 1994

MERCK: U.S. Migraine Assessment Program (Maxalt), 1999


ACT: Cleveland Clinic-Biogen 2004

OPEXA: Tamoxofen MS Trial 2006

TEVA: interferon antibodies. PM028  2006

ALLERGAN: Overactive bladder in MS 2007

BIOMS: mbp8298 for secondary progressive MS. 2007


GLAXOSMITHKLINE: GSK716155. Treatment of Diabetes type 2. 2007.


MEM MD 19: Forest Labs 2004

SCHWARZ PHARMA: SPM927 for Diabetic Neuropathy: SP 768 study, 2004-05

ORTHO MCNEIL:  Tramadol Neuropathy Trial, 2004

ALLERGAN: Painful Diabetic Neuropathy. 203818. 2007

SANGAMO: SB-509 for Diabetic Neuropathy. 2007


PfFIZER: Pregablin in the Treatment of Back Pain, 1999

PFIZER: Pregablin in the Treatment of Post-Herpetic Neuralgia, 2000

NEUROGESIX: NGX4010, PHN:  2003, 2005

DEPOMED:  gabapentin in postherpetic neuralgia, 2005

NEUROGESIX: NGX-4010 for postherpetic neuralgia, 2005

PFIZER: PHN trial, 2006

DURECT: Clin005-0009 Bupivicaine for PHN. 2007.

KING PHARMACEUTICALS: K862-06-2001  T-62 for PHN. 2007.


SANDOZ: Parlodel in the treatment of Parkinson’s Disease, 1979, University of Arizona

BOEHRINGER-INGELHEIM: NS2330, Parkinsons: 2003-2004

NOVARTIS:  Stalevo End of Dose Study:  2005

MERK:  PADDY 1 trial for Parkinson’s treatment associated dyskinesia, 2005

OVATION:   Hallucinations with Parkinson’s Disease Treatment, 2005

BOEHRINGER INGELHEIM: Pramipaxol in Early Parkinsons. 2005-6

SCHWARZ PHARMACEUTICALS: SP921.  Rotigotine Transdermal System in advanced Parkinson’s. 2007.   


LOREX: Eliprodil for Treatment of Cerebral Infarct, 1996-97



ROCKET: Duke University, Rivaroxaman for CVA prevention in Atrial Fibrillation, 2007


Florida: ME 0033896

Arizona: 15779

South Carolina: 13324

North Carolina: 112232


AMA Physician Recognition Award: 1982, 1985, 1988, 1991, 1994, 1997, 2000, 2004

AMA Physician Recognition Award with Commendation: 2007

Epilepsy Foundation of Southwest Florida Outstanding Patient Service Award, 1994

Fellow, American Academy of Neurology, 1998

Strathmore’s Who’s Who, 1999

Guide To Top Doctors, 1999, 2006: Center for the Study of Services

Marquis “Who’s Who in Medicine and Healthcare”, 2000-2001

Gold Quill Award, Manatee Memorial Hospital, November  2000; November 2009

Marquis “Who’s Who in Finance and Industry”, 2002-2003

U.S News and World Report. "Top Doctor" 2011



McElveen WA. “Post-Herpetic Neuralgia”: eMedicine Journal: Neurology [serial online].  April, 2001, volume 2, number 4. Available at

McElveen, WA. “Cerebral Venous Thrombosis”: eMedicine Journal: Neurology [serial online]. January 2001, volume 2, number 1. Available at

Dworkin RH et al. “Pregabalin for the Treatment of Postherpetic Neuralgia” Neurology:

2003;60:1274-1283  (Investigator)

McElveen, WA and Alway, D. (2009)  “Ischemic Stroke and Transient Ischemic Attack: Evaluation and Management” Stroke Essentials for Primary Care  Ed Alway, D and Cole, JW.  Humana Press. pp 9-34. 
McElveen, WA (2009)  “Cerebral Venous Thrombosis” Stroke Essentials for Primary Care  Ed: Alway, D and Cole, JW. Humana Press. pp 183-194
McElveen, WA and Macko, R.(2009)  “Pathophysiology and Management of Acute Stroke”  Stroke Recovery and Rehabilitation.  ed: Stein, J et al.  demosMEDICAL.  pp 45-59
McElveen, WA(2009)Management of Sinovenous Thrombosis” Stroke: A Practical Approach  Ed: Geyer, JD. and Gomez, CR. Lippincott Williams & Wilkins. pp 308-311



MRI Fellowship Program, CME certification by American Society of Neuroimaging. June 29, 2002, Orlando, FL

MRI Fellowship Program, CME certification by American Society of Neuroimaging, “MRI in Multiple Sclerosis” February 8-9, 2003, Sarasota, FL

Stroke Certification Program, CME certification by Blake Medical Center, “Tools of the Trade…Neurological Assessment” March 9, 2005, Bradenton, FL

Optimizing Stroke Service Line Management, WRG Research, Inc  “The Physician as Champion for Stroke Unit” June 21, 2007, Arlington, VA

Enter content here

Enter content here

Enter content here